SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Thyroid Meds Recalled Nationwide; Life Expectancy Rebounds; Cannabis Use Hits Record

Health news and commentary gathered by MedPage Today staff

The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify

The $50 price under the program applies only to people using the drug solely for weight loss

'Gray Market' Retatrutide Study; Menopause and the Brain; Drug Allergy Warnings

News and commentary from the endocrinology world

FDA Authorizes First Wearable Dual Glucose-Ketone Sensor

System offers real-time diabetic ketoacidosis warnings

Todays Updates

Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis

— Rival to the Agent DCB had been shown noninferior to DES

Todays Updates

Selution SLR Drug-Eluting Balloon Gets FDA Nod for Coronary In-Stent Restenosis

— Rival to the Agent DCB had been shown noninferior to DES

Latest News

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Health news and commentary gathered by MedPage Today staff

The $50 price under the program applies only to people using the drug solely for weight loss

News and commentary from the endocrinology world

System offers real-time diabetic ketoacidosis warnings

News All Time

Endometriosis Can Elude Diagnosis for Years. What to Know About New Ways to Find It.

New tests available abroad are raising hope among doctors and patients

New GLP-1 Hair Loss Insights; Wegovy in Kids; Are Fitness Trackers Lying to Users?

News and commentary from the endocrinology world

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

TIMBERLINE study shows good safety and sweat chloride reductions with triple combo CFTR modulator

Menopausal Hormone Therapy May Ease Severe Mood Symptoms

Therapy also associated with better sleep scores in non-controlled study

The CDC Division I Spent 15 Years Building Is in Peril

Cuts to the Division of Nutrition, Physical Activity, and Obesity will not make America healthy

The Market Forces Quietly Adding Thousands to Patient Bills

A look at a shifting industry

Preserving Muscle During GLP-1 Weight Loss

Experts advise tracking body composition, boosting protein, and resistance training

Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility

News and commentary from the endocrinology world

ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space

MedPage Today reporters offer further insights into recently covered topics

Pentagon Revives Testosterone Testing After Pause, Excludes Women

The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson ⁠said on Thursday, bringing...

Osteoporosis: Are Bone Density Targets Worth Chasing?

Specialists debate the value of specific bone density goals with concerns that measurement variability and limited trial evidence may complicate treatment decisions.

GLP-1 Systematic Review Finds Weight Loss of Up to 24%

GLP-1 drugs are associated with substantial weight loss in adults without diabetes, and the range of options, including oral and multiagonist therapies, is expanding.

Nurse-Led Digital Therapeutics Boosts Diabetes Outcomes

A structured nurse-led digital therapeutics pathway is linked to higher adherence and more favorable metabolic outcomes than usual care in adults with type 2 diabetes, a study reports.

FDA Approves Generic Lutathera for Adults With GEP-NETs

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Could Psilocybin Prevent Nerve Damage From Chemotherapy?

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

Body-Related TikTok Reels Tied to Self-Objectification, Mood

Viewing appearance-focused TikTok videos is associated with increased self-objectification in women, as well as changes in mood.

Recommended News For You

investigating radiation oncology applications of artificial general intelligence.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

A protein with new anticancer activity has been identified

Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

Recommended Articles For You

Hematology Laboratory Simulation: Advancing Clinical Competence through Technology-Driven Training 

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies 

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium 

Public Health Through Cancer Survivorship Infrastructure at the Community Level 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

2.

Researchers discuss HER2-low and HER2-zero in breast cancer

3.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

4.

Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds

5.

Waiting for a Sharp Increase in Prostate Cancer Cases.

1.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

2.

Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics

3.

Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy

4.

How HLH is Revolutionizing Healthcare

5.

Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

How Advances in Cancer Research Are Improving Treatment Options

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

3.

Navigating the Complexities of Ph Negative ALL - Part XIV

4.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot